RecruitingPhase 3NCT07467083

Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy


Sponsor

West China Hospital

Enrollment

170 participants

Start Date

Mar 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to investigate whether a nurse-led preemptive symptom management protocol can reduce the radiation therapy interruption rate in patients with head and neck cancer compared to conventional care models.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

  • Patients had pathologically confirmed malignant head and neck tumors without distant metastasis.
  • Patient age ≥18 years; Patients were scheduled to undergo either postoperative adjuvant radiotherapy or radical radiotherapy, with or without concurrent chemotherapy.
  • Baseline ECOG (Eastern Cooperative Oncology Group) score 0-2;
  • Good cognitive and reading skills, able to complete the questionnaire survey.

Exclusion Criteria4

  • Presence of other malignant tumors aside from head and neck malignancies;
  • A history of prior head and neck radiotherapy;
  • Mental illness or cognitive impairments;
  • Uncontrolled systemic diseases that could significantly affect their QoL.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALNurse-led preemptive symptom management

The intervention encompasses four key components: symptom monitoring and management guided by a standardized manual, emotional and psychological support integrating family involvement and traditional cultural values, family-unit-based education and skills training, and care coordination ensuring multidisciplinary communication.

BEHAVIORALConcentional care

Conventional care encompasses basic nursing care and routine health education, including instruction related to radiotherapy.


Locations(1)

West China Hospital of Sichuan University

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07467083


Related Trials